RETACRIT 40000 [iU]/mL (Epoetin Alfa-Epbx INJECTION, SOLUTION) 40000 [iU]/mL

RETACRIT 40000 [iU]/mL is an injectable solution containing epoetin alfa-epbx, used to support red blood cell production. This medication is administered intravenously or subcutaneously and is available in single-dose vials.

Strength

40000 [iU]/mL

Pack Size

4 VIAL, SINGLE-DOSE in 1 CARTON (0069-1309-04) / 1 mL in 1 VIAL, SINGLE-DOSE (0069-1309-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETACRIT 40000 [iU]/mL is primarily used to treat anemia associated with chronic kidney disease and to support red blood cell production in patients undergoing chemotherapy. It is often prescribed to individuals who require erythropoietin therapy to manage low red blood cell counts. The medication works by stimulating the bone marrow to produce more red blood cells, which can help improve oxygen delivery throughout the body.

Side Effects

Common effects of RETACRIT 40000 [iU]/mL may include injection site reactions such as redness, swelling, or pain. Some individuals may experience flu-like symptoms, including fever, chills, or muscle aches. It is important to monitor for any signs of allergic reactions, which can include rash, itching, or difficulty breathing.

Precautions & Warnings

RETACRIT 40000 [iU]/mL should be handled with care and administered under the supervision of a healthcare professional. It is important to follow proper storage guidelines to maintain the medication's effectiveness. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment. Regular blood tests may be required to monitor red blood cell levels and overall response to the medication.

Avoid Interactions

RETACRIT 40000 [iU]/mL may interact with certain medications, including those that affect blood clotting or immune system function. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated, as it may affect the body's response to the medication. Always consult a healthcare professional for personalized advice.

Frequently Asked Questions

RETACRIT 40000 [iU]/mL is used to treat anemia associated with chronic kidney disease and to support red blood cell production in patients undergoing chemotherapy.

RETACRIT 40000 [iU]/mL is administered either intravenously or subcutaneously, depending on the patient's needs and healthcare provider's instructions.

Common side effects may include injection site reactions, flu-like symptoms, and allergic reactions. Always consult a healthcare provider for personalized advice.

RETACRIT 40000 [iU]/mL may interact with certain medications, so it is important to discuss all current medications with a healthcare provider.

RETACRIT 40000 [iU]/mL should be stored according to the manufacturer's guidelines to maintain its effectiveness. Always follow proper storage instructions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.